Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Topics Community

Article

ASO Author Reflections: Performance of Contralateral Risk-Reducing Mastectomy in Multigene Panel-Tested Patients is High in All Types of Germline Mutation Carriers.

Annals of surgical oncology - 1 Dec 2020

Murphy Brittany L, Bedrosian Isabelle

Abstract excerpt

No abstract is available from the source.

Topics

Breast Neoplasms
Germ-Line Mutation
Heterozygote
Humans
Mastectomy
Mutation

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 32712892
DOI: 10.1245/s10434-020-08931-7

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

ASO Author Reflections: Performance of Contralateral Risk-Reducing Mastectomy in Multigene Panel-Tested Patients is High in All Types of Germline Mutation Carriers.PMID 32712892Read ↗

ASO Author Reflections: Prophylactic Nipple-Sparing Mastectomy as an Effective Risk-Reducing Strategy for BRCA Mutation Carriers.Semantic proximity Read ↗

Contralateral Risk-Reducing Mastectomy in Breast Cancer Patients Who Undergo Multigene Panel Testing.Semantic proximity Read ↗

Contralateral prophylactic mastectomy rate and predictive factors among patients with breast cancer who underwent multigene panel testing for hereditary cancer.Semantic proximity Read ↗

Points to Consider Regarding Risk-Reducing Mastectomy in High-, Moderate-, and Low-Penetrance Gene Carriers.Semantic proximity Read ↗

Impact of Multigene Panel Testing on Surgical Decision Making in Breast Cancer Patients.Semantic proximity Read ↗

Prophylactic mastectomies in patients with breast cancer and known germline pathogenetic variants: an Austrian registrySemantic proximity Read ↗

Attitude of BRCA1/2 mutation carriers towards surgical risk reduction for breast, ovarian and uterine cancer: still much to be done.Semantic proximity Read ↗

Risk-reducing surgery for individuals with cancer-predisposing germline pathogenic variants and no personal cancer history: a review of current UK guidelines.Semantic proximity Read ↗

Mastectomy for risk reduction or symmetry in women without high risk gene mutation: A review.Semantic proximity Read ↗

Influence of germline test results on surgical decision making in women with invasive breast cancer.Semantic proximity Read ↗

Risk reducing mastectomy in Norwegian BRCA1/2 carriers.Semantic proximity Read ↗

Outcomes of large panel genetic evaluation of breast cancer patients in a community-based cancer institute.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.